Sunday, February 25

Lab Automation market, Size and Share by 2035

The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks.

As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory.

The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:

  • Type of Instrument
  • Automated Liquid Handling Systems
  • Automated Microplate Readers
  • Automated Sampling Systems
  • Analyzers
  • Automated Storage and Retrieval Systems (ASRS)
  • Other Instruments
  • End-User
  • Pharmaceutical and Biotechnology Companies
  • Research and Diagnostic Laboratories
  • Other End-Users
  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:

  • Abbott
  • Anton Paar
  • BD
  • Beckman Coulter
  • ERWEKA
  • Leuze
  • Ortho Clinical Diagnostics
  • Pall Corporation
  • PerkinElmer
  • Roche Diagnostics
  • Siemens Healthineers
  • SYSTAG

Table of Contents

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Partnerships and Collaborations

8. Patent Analysis

9. Market Forecast and Opportunity Analysis

10. Case Study: Lab Automation Software

11. Executive Insights

12. Appendix 1: Tabulated Data

13. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/lab-automation-market.html

News article

Biopharmaceutical Filtration Market

Learn from experts:  do you know about these emerging industry trends?

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

T-cell Immunotherapies: The Future of Modern Cancer Treatments

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting – the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

Leave a Reply

Your email address will not be published. Required fields are marked *